|
1
|
Ricard D, Idbaih A, Ducray F, Lahutte M,
Hoang-Xuan K and Delattre JY: Primary brain tumours in adults.
Lancet. 379:1984–1996. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Louis DN, Ohgaki H, Wiestler OD, Cavenee
WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007
WHO classification of tumours of the central nervous system. Acta
Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
van den Bent MJ: Interobserver variation
of the histopathological diagnosis in clinical trials on glioma: A
clinician's perspective. Acta Neuropathol. 120:297–304. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Joseph JV, Balasubramaniyan V, Walenkamp A
and Kruyt FA: TGF-β as a therapeutic target in high grade
gliomas-promises and challenges. Biochem Pharmacol. 85:478–485.
2013. View Article : Google Scholar
|
|
5
|
Nicolaidis S: Biomarkers of glioblastoma
multiforme. Metabolism. 64(3 Suppl 1): S22–S27. 2015. View Article : Google Scholar
|
|
6
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rolle K: miRNA Multiplayers in glioma.
From bench to bedside. Acta Biochim Pol. 62:353–365. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lv XB, Jiao Y, Qing Y, Hu H, Cui X, Lin T,
Song E and Yu F: miR-124 suppresses multiple steps of breast cancer
metastasis by targeting a cohort of pro-metastatic genes in vitro.
Chin J Cancer. 30:821–830. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ando T, Yoshida T, Enomoto S, Asada K,
Tatematsu M, Ichinose M, Sugiyama T and Ushijima T: DNA methylation
of microRNA genes in gastric mucosae of gastric cancer patients:
Its possible involvement in the formation of epigenetic field
defect. Int J Cancer. 124:2367–2374. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Agirre X, Vilas-Zornoza A, Jiménez-Velasco
A, Martin-Subero JI, Cordeu L, Gárate L, San José-Eneriz E,
Abizanda G, Rodríguez-Otero P, Fortes P, et al: Epigenetic
silencing of the tumor suppressor microRNA Hsa-miR-124a regulates
CDK6 expression and confers a poor prognosis in acute lymphoblastic
leukemia. Cancer Res. 69:4443–4453. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lujambio A, Ropero S, Ballestar E, Fraga
MF, Cerrato C, Setién F, Casado S, Suarez-Gauthier A,
Sanchez-Cespedes M, Git A, et al: Genetic unmasking of an
epigenetically silenced microRNA in human cancer cells. Cancer Res.
67:1424–1429. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lv Z and Zhao Y: MiR-124 inhibits cell
proliferation, invasion, and migration in glioma by targeting
Smad2. Int J Clin Exp Pathol. 10:11369–11376. 2017.PubMed/NCBI
|
|
14
|
Deng D, Luo K, Liu H, Nie X, Xue L, Wang
R, Xu Y, Cui J, Shao N and Zhi F: p62 acts as an oncogene and is
targeted by miR-124-3p in glioma. Cancer Cell Int. 19:2802019.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Song S, Fajol A, Tu X, Ren B and Shi S:
miR-204 suppresses the development and progression of human
glioblastoma by targeting ATF2. Oncotarget. 7:70058–70065. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
17
|
Hu T, Li YS, Chen B, Chang YF, Liu GC,
Hong Y, Chen HL and Xiyang YB: Elevated glucose-6-phosphate
dehydrogenase expression in the cervical cancer cases is associated
with the cancerigenic event of high-risk human papillomaviruses.
Exp Biol Med (Maywood). 240:1287–1297. 2015. View Article : Google Scholar
|
|
18
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
John B, Enright AJ, Aravin A, Tuschl T,
Sander C and Marks DS: Human MicroRNA targets. PLoS Biol.
2:e3632004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Krek A, Grün D, Poy MN, Wolf R, Rosenberg
L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M
and Rajewsky N: Combinatorial microRNA target predictions. Nat
Genet. 37:495–500. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Samson T, Welch C, Monaghan-Benson E, Hahn
KM and Burridge K: Endogenous RhoG is rapidly activated after
epidermal growth factor stimulation through multiple
guanine-nucleotide exchange factors. Mol Biol Cell. 21:1629–1642.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
He Z, Huang C, Lin G and Ye Y:
siRNA-induced TRAF6 knockdown promotes the apoptosis and inhibits
the invasion of human lung cancer SPC-A1 cells. Oncol Rep.
35:1933–1940. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liang L, Wong CM, Ying Q, Fan DN, Huang S,
Ding J, Yao J, Yan M, Li J, Yao M, et al: MicroRNA-125b
suppressesed human liver cancer cell proliferation and metastasis
by directly targeting oncogene LIN28B2. Hepatology. 52:1731–1740.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
He Z, Xia Y, Liu B, Qi X, Li Z, Wang J,
Chen L and Chen Y: Down-regulation of miR-452 is associated with
poor prognosis in the non-small-cell lung cancer. J Thorac Dis.
8:894–900. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang H and Wang Y: Five miRNAs considered
as molecular targets for predicting neuroglioma. Tumour Biol.
37:1051–1059. 2016. View Article : Google Scholar
|
|
26
|
Qiu S, Lin S, Hu D, Feng Y, Tan Y and Peng
Y: Interactions of miR-323/miR-326/miR-329 and
miR-130a/miR-155/miR-210 as prognostic indicators for clinical
outcome of glioblastoma patients. J Transl Med. 11:102013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu X, Fortin K and Mourelatos Z:
MicroRNAs: Biogenesis and molecular functions. Brain Pathol.
18:113–121. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang WX, Wilfred BR, Hu Y, Stromberg AJ
and Nelson PT: Anti-Argonaute RIP-Chip shows that miRNA
transfections alter global patterns of mRNA recruitment to
microribonucleoprotein complexes. RNA. 16:394–404. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Baek D, Villén J, Shin C, Camargo FD, Gygi
SP and Bartel DP: The impact of microRNAs on protein output.
Nature. 455:64–71. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Miranda KC, Huynh T, Tay Y, Ang YS, Tam
WL, Thomson AM, Lim B and Rigoutsos I: A pattern-based method for
the identification of MicroRNA binding sites and their
corresponding heteroduplexes. Cell. 126:1203–1217. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Franke K, Otto W, Johannes S, Baumgart J,
Nitsch R and Schumacher S: miR-124-regulated RhoG reduces neuronal
process complexity via ELMO/Dock180/Rac1 and Cdc42 signalling. EMBO
J. 31:2908–2921. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Schumacher S and Franke K:
miR-124-regulated RhoG: A conductor of neuronal process complexity.
Small GTPases. 4:42–46. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Etienne-Manneville S and Hall A: Rho
GTPases in cell biology. Nature. 420:629–635. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sahai E and Marshall CJ: RHO-GTPases and
cancer. Nat Rev Cancer. 2:133–142. 2002. View Article : Google Scholar
|
|
35
|
Vega FM and Ridley AJ: Rho GTPases in
cancer cell biology. FEBS Lett. 582:2093–2101. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Katoh H and Negishi M: RhoG activates Rac1
by direct interaction with the Dock180-binding protein Elmo.
Nature. 424:461–464. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hiramoto K, Negishi M and Katoh H: Dock4
is regulated by RhoG and promotes Rac-dependent cell migration. Exp
Cell Res. 312:4205–4216. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Elfenbein, Rhodes JM, Meller J, Schwartz
MA, Matsuda M and Simons M: Suppression of RhoG activity is
mediated by a syndecan 4-synectin-RhoGDI1 complex and is reversed
by PKCalpha in a Rac1 activation pathway. J Cell Biol. 186:75–83.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Fortin Ensign SP, Mathews IT, Eschbacher
JM, Loftus JC, Symons MH and Tran NL: The Src homology 3
domain-containing guanine nucleotide exchange factor is
overexpressed in high-grade gliomas and promotes tumor necrosis
factor-like weak inducer of apoptosis-fibroblast growth
factor-inducible 14-induced cell migration and invasion via tumor
necrosis factor receptor-associated factor 2. J Biol Chem.
288:21887–21897. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Krasilnikov MA: Phosphatidylinositol-3
kinase dependent pathways: The role in control of cell growth,
survival, and malignant transformation. Biochemistry (Mosc).
65:59–67. 2000.
|
|
41
|
Murga C, Zohar M, Teramoto H and Gutkind
JS: Rac1 and RhoG promote cell survival by the activation of PI3K
and Akt, independently of their ability to stimulate JNK and
NF-kappaB. Oncogene. 21:207–216. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yamaki N, Negishi M and Katoh H: RhoG
regulates anoikis through a phosphatidylinositol 3-kinase-dependent
mechanism. Exp Cell Res. 313:2821–2832. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zheng F, Liao YJ, Cai MY, Liu YH, Liu TH,
Chen SP, Bian XW, Guan XY, Lin MC, Zeng YX, et al: The putative
tumour suppressor microRNA-124 modulates hepatocellular carcinoma
cell aggressiveness by repressing ROCK2 and EZH2. Gut. 61:278–289.
2012. View Article : Google Scholar
|
|
44
|
Chien W, O'Kelly J, Lu D, Leiter A, Sohn
J, Yin D, Karlan B, Vadgama J, Lyons KM and Koeffler HP: Expression
of connective tissue growth factor (CTGF/CCN2) in breast cancer
cells is associated with increased migration and angiogenesis. Int
J Oncol. 38:1741–1747. 2011.PubMed/NCBI
|
|
45
|
Fowler A, Thomson D, Giles K, Maleki S,
Mreich E, Wheeler H, Leedman P, Biggs M, Cook R, Little N, et al:
miR-124a is frequently down-regulated in glioblastoma and is
involved in migration and invasion. Eur J Cancer. 47:953–963. 2011.
View Article : Google Scholar : PubMed/NCBI
|
